The other genome: Clinical spectrum of mitochondrial cytopathies or oxidative phosphorylation diseases;El otro genoma: El concepto clínico de las citopatías mitocondriales o enfermedades de la fosforilación oxidativa

Revista de Investigacion Clinica

Volumn 51, Issue 2, 1999, Pages 121-134

  Barrera Ramírez, Carlos Felipe ^a   Barragán Campos, Héctor Manuel ^b   Sánchez Guerrero, Jorge ^b   García Ramos, Guillermo ^b   Vega Boada, Felipe ^b   Estañol, Bruno ^b  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Kearns Sayre syndrome; MELAS; MERRF; Mitochondrial cytopathies; Oxidative phosphorylation diseases

Indexed keywords

LACTIC ACID; MITOCHONDRIAL DNA; PYRUVIC ACID;

BLOOD; CARDIOMYOPATHY; DIFFERENTIAL DIAGNOSIS; EXTRACHROMOSOMAL INHERITANCE; FEMALE; GENETICS; GENOME; HEREDITARY OPTIC ATROPHY; HUMAN; MALE; MITOCHONDRIAL MYOPATHY; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; REVIEW;

CARDIOMYOPATHIES; DIAGNOSIS, DIFFERENTIAL; DNA, MITOCHONDRIAL; EXTRACHROMOSOMAL INHERITANCE; FEMALE; GENOME; HUMANS; LACTIC ACID; MALE; MITOCHONDRIAL MYOPATHIES; OPTIC ATROPHIES, HEREDITARY; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PYRUVIC ACID;

EID: 0346451281     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (110)

1. DiMauro S, Moraes CT. Mitochondrial encephalomyopathies. Arch Neurol 1993; 50: 1197-208.
2. Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF et al. Mitochondrial DNA deletion in progressive external opthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989; 320: 1293-9.
3. Anderson S, Bankier AT, Barrell BG, de Bruijn MHL, Coulson AR, Drouin J et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457-65.
4. Wallace DC. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 1992; 256: 628-32.
5. Beal MF. Aging, energy and oxidative stress in neurodegenerative diseases. Ann Neurol 1995; 38: 357-66.
6. Fadic R, Johns DR. Clinical spectrum of mitochondrial diseases. Semin Neurol 1996; 16: 11-20.
7. DiMauro S. Mitochondrial encephalomyopathies: What next? J Inherit Metab Dis 1996; 19: 489-503.
8. Wikström M, Krab K, Saraste M. Proton-traslocating cytochrome complexes. Ann Rev Biochem 1981; 50: 623-55.
9. Olson MS. Bioenergetics and oxidative metabolism. In: Devlin TM, Aktipis S, Angstadt CN (eds). Textbook of Biochemistry: with clinical correlations. New York, USA: Willey-Lis 1992: 237-87.
10. Pfanner N, Neupert W. A mitochondrial machinery for membrane traslocation of precursor proteins. Biochem Soc Trans 1990; 18: 513-5.
11. Servidei S, Zeviani M, Manfredi G, Ricci E, Silvestri G, Bertini E et al. Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA: clinical morphologic and biochemical studies. Neurology 1991; 41: 1053-9.
12. Zeviani M, Amati P, Savoia A. Mitochondrial myopathies. Curr Opin Rheuma 1994; 6: 559-67.
13. Wallace DC. Diseases of the mitochondrial DNA. Annu Rev Biochem 1992; 61: 1175-212.
14. Ohno K, Tanaka M, Sahashi K. Mitochondrial DNA deletions in inherited recurrent myoglobinuria. Ann Neurol 1991; 29: 364-9.
15. Zeviani M, Bresolin N, Gallera C. Nucleus-driven multiple large-scale deletions of the human mitochondrial genome: a new autosomal dominant disease. Am J Hum Genet 1990; 47: 904-14.
16. Zeviani M, Servendi S, Gellera C, Bertini E, DiMauro S, DiDonato S. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 1989; 339: 309-11.
17. Moraes CT, Shanske S, Tritschler HJ. MtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 1991; 48: 492-501.
18. Pearson HA, Lobel JS, Kocoshis SA, Naiman JL, Windmiller J, Lammi AT et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic function. J Pediatr 1979; 95: 976.
19. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequinot E et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995; 11: 144-9.
20. Shanske S, DiMauro S. Mitochondrial myopathies: Biochemical aspects. Curr Top Bioener 1994; 17: 21-58.
21. Shoffner JM. Maternal inheritance and the evaluation of oxidative phosphorylation diseases, lancet 1996; 348: 1283-88
22. Luft R, Ikkos D, Palmieri G. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical and morphological study. J Clin Invest 1962; 41: 1776-804.
23. Shapira Y, Harel S, Russell A. Mitochondrial encephalopathy: a group of neuromuscular disorders with defects in oxidative metabolism. Isr J Med Sci 1977; 13: 161-4.
24. Egger J, Lake BD, Wilson J. Mytochondrial cytopathy. A multisystem disorder with ragged-red fibers on muscle biopsy. Arch Dis Child 1981; 56: 741-52.
25. DiMauro S, Bonilla E, Zeviani M, Nakawaga M, DeVivo DC. Mitochondrial myopathies. Ann Neurol 1985; 17: 521-38.
26. Drachman DA. Ophtalmoplegia-plus: The neurodegenerative disorders associated with progressive external ophtalmoplegia. Arch Neurol 1968; 18: 654.
27. Berenberg RA, Pellock JM, DiMauro S et al. Lumping or splitting? "Ophthalmoplegia-plus" or Kearns-Sayre syndrome? Ann Neurol 1977; 1: 37-54.
28. Holt IJ, Miller DH, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myophaties. Nature 1988; 331: 717-9.
29. Kosmorsky C, Johns DR. Neuro-ophthalmologic manifestations of mitochondrial DNA disorders: Chronic progressive external ophthalmoplegia, Kearns-Sayre syndrome, and Leber's hereditary optic neuropathy. Neurol Clin 1991; 9: 147-61.
30. Kearns TP, Sayre GP. Retinitis pigmentosa, external ophthalmoplegia and complete heart block: unusual syndrome with histologic study in one of two cases. Arch Ophthalmol 1958; 60: 280-9.
31. Bartley GB. Ophthalmic eponyms from the Mayo Clinic. Mayo Clin Proc 1997; 72: 990-5.
32. Poll-The BT, Billette de Villemeur T, Abitbol M, Dufier JL, Saudubray JM. Metabolic pigmentary retinopathies: diagnosis and therapeutic attempts. Eur J Pediatr 1992; 151: 2-11.
33. Isashiki Y, Nakagawa M, Ohba N, Kamimura K, Sakoda Y, Higuchi I, Izumo S, Osame M. Retinal manifestations in mitochondrial diseases associated with mitochondrial DNA mutation. Acta Ophthalmol Scand 1998; 76: 6-13.
34. Johns DR. Mitochondrial DNA and disease. N Eng J Med 1995; 333: 638-44.
35. Rowland LR Molecular genetics, pseudogenetics and clinical neurology. Neurology (Cleveland) 1983; 33: 1179-95.
36. Bastiaensen LAK, Frenken CWGM, Ter Laak HJ, Jaspar HH, Stadhouders AM, Ruitenbeek W, Veerkamp JH. Kearns syndrome: a heterogeneous group of disorders with CPEO, or a nosological entity? Doc Ophthalmol 1982; 52: 207-55.
37. Mitsumoto H, Aprille JR, Wray SH, Nemni R, Bradley WG. Chronic progressive external ophthalmoplegia (CPEO): Clinical, morphological and biochemical studies. Neurology 1983; 33: 452-61.
38. Johnson MA, Turnbull DM, Dick DJ, Sherrat HSA. A partial deficiency of cytochrome c oxidase in chronic progressive ophthalmoplegia. J Neurol Sci 1983; 60: 31-53.
39. Turnbull DM, Johnson MA, Dick DJ, Cartlidge NE, Sherratt HS. Partial cytochrome oxidase deficiency without subsarcolemmal accumulation of mitochondria in chronic progressive external ophthalmoplegia. J Neurol Sci 1985; 70: 93-100.
40. Yorifuji S, Ogasahara S, Takahashi M, Tarui S. Decreased activities in mitochondrial inner membrane electron transport from patients with Kearns-Sayre syndrome. J Neurol Sci 1985; 71: 65-75.
41. Eymard B. Les myopathies mitochondriales. Rev Prat (Paris) 1988; 38: 1522-8..
42. Pedrote A, Varela JM, Sánchez A, Gil-Neciga E, Acosta D, Errazquín F, Burgos J. Bloqueo atrioventricular en el síndrome de Kearns-Sayre. Rev Esp Cardiol 1990; 43: 192-4.
43. Kenny D, Wetherbee J. Kearns-Sayre syndrome in the elderly: Mitochondrial myopathy with advanced heart block. An Heart L 1990; 120: 440-3.
44. Anan R, Nakagawa M, Miyata M, Higuchi I, Nakao S, Suehara M et al. Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation 1995; 91: 955-61.
45. Hocker-Muller J, Jacob U, Seibel P. The common 4977 base pair deletion of mitochondrial DNA preferentially accumulates in the cardiac conduction system of patients with Kearns-Sayre syndrome. Mod Pathol 1998; 11: 295-301.
46. Tengan CH, Kiyomoto BH, Rochas MS, Tavares VL, Gabbai AA, Moraes CT. Mtochondrial encephalomyopathy and hypoparathyroidism associated with a duplication and a deletion of mitochondrial deoxyribonucleic acid. J Clin Endocrinol Metab 1998; 83: 125-9.
47. Papadimitriou A, Hadjigeorgiou GM, Divari R, Papagalanis N, Comi G, Bresolin N. The influence of coenzyme Q10 on total serum calcium concentration in two patients with Kearns-Sayre syndrome and hypoparathyroidism. Neuromusc Disord 1996; 6: 49-53.
48. Demange P, Pam-Gia H, Kalifa G, Sellier N. MR of Kearns-Sayre syndrome. AJNR 1989; 10: S91.
49. Egger RC, Wynne-Williams CJ, Erdchazi M. Mitochondrial cytopathy or Leigh's syndrome: Mitochondrial abnormalities in spongiform encephalophaties. Neuropediatrics 1982; 13: 219-24.
50. Fukuhara N, Tokiguchi S, Shirakawa S, Tsubaki T. Myoclonus epilepsy associated with ragged-red fibers (mitochondrial abnormalities): Disease entity or syndrome? Light and electronmicroscopic studies of two cases and review of the literature. J Neurol Sci 1980; 47: 117-33.
51. Rosing HS, Hopkins LC, Wallace DC. Maternally inherited mitochondrial myophaty and myoclonic epilepsy. Ann Neurol 1985; 17: 228-37.
52. Franceschetti S, Antozzi C, Binelli, Carrara F, Nardocci N, Zeviani M, Avanzini C. Progressive myoclonus epilepsies: An electroclinical, biochemical, morphological and molecular genetic study of 17 cases. Acta Neurol Scand 1993; 87: 219-23.
53. De Vries DD, de Wijs IJ, Wolff G, Ketelsen UP, Ropers HH, van Oost BA. X-linked myoclonus epilepsy explained as a maternally inherited mitochondrial disorder. Hum Genet 1993; 91: 51-4.
54. Silvestri G, Ciafaloni E, Santorelli FM, Shanske S, Servidei S, Graf WD, Suni M, DiMauro S. Clinical features associated with the A → G transition al nucleotide 8344 of mtDNA ("MERRF mutation"). Neurology 1993; 43: 1200-6.
55. Moraes CT, Ciacci F, Silvestri G, Shanske S, Sciacco M, Hirano M, Schon EA, Bonilla E, DiMauro S. Atypical clinical presentation associated with de MELAS mutation al position 3243 of human mitochondrial DNA. Neuromusc Disord 1993; 3: 43-50.
56. Remes AM, Majamaa K, Herva R, Hassinen IE. Adult-onset diabetes mellitus and neurosensory hearing loss in maternal relative of MELAS patients in a family with the tRNA(Leu(UUR)) mutation. Neurology 1993; 43: 1015-20.
57. Singh PJ, Santella R, Zawada ET. Mitochondrial genome mutations and kidney disease. Am J Kidney Dis 1996; 28: 140-6.
58. Wallace DC, Singh G, Lott MT. Mitochondrial DNA mutation associated with Leber's hereditary optic neurophathy. Science 1988; 242: 1427-30.
59. Riordan-Eva P, Sanders MD, Govan GG. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 1995; 118: 319-37.
60. Newman NJ. Leber's hereditary optic neuropathy: new genetic considerations. Arch Neurol 1993; 50: 540-8.
61. Schon EA, Hirano M, DiMauro S. Mitochondrial encephalomyopathies: clinical and molecular analysis. J Bioenerg Biomembr 1994; 26: 291-9.
62. Petty RKH, Harding AE, Morgan-Hughes JA. The clinical features of mitochondrial myopathy. Brain 1986; 109: 915-38.
63. Austin SG, Thandroyen FT, Hecht JT, Vriesendorp FJ, Jones OW, Johns DR. Expanding the phenotype of the 8344 t RNAlys mitochondrial DNA mutation. Neurology 1994; 44: Supl 2: A403.
64. Lewy P, Leroy G, Haiat R, Halphen C, Kerrad L, Sander M, Weingrod M. Syndrome de Kearns-Sayre. Une indication rare d'implantation prophylactique de pacemaker. Arch Mal Coeur 1997; 90: 93-7.
65. Martínez JL, Bello L, Casariego JR, Mazón P, Vigil-Escalera P, Rodríguez A. Prolapso mitral en un paciente con síndrome de Kearns-Sayre. Rev Esp Cardiol 1987; 40: 60-2.
66. Akaike M, Kawai H, Yokoi K, Kunishige M, Mine H, Nishida Y, Saito S. Cardiac dysfunction in patients with chronic progressive external ophthalmoplegia. Clin Cardiol 1997; 20: 239-43.
67. Suzuki Y, Harada K, Miura Y, Sato W, Hayasaka K, Kawamura K, Takada G. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) decreased in diastolic left ventricular function assessed by echocardiography. Pediatr Cardiol 1993; 14: 162-6.
68. Van den Ouweland JM, Lemkes PJ, Ruitenbeek W, Sandkuijl LA, de Vijlder MF, Struyvenberg PA et al. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type Il diabetes mellitus and deafness. Nat Genet 1992; 1: 368-71.
69. Gerbitz KD. Does the mitochondrial DNA play a role in the development of diabetes? Diabetologia 1992; 35: 1181-6.
70. Gerbitz KD, Gempel K, Brdiczka D. Mitochondria and diabetes. Diabetes 1996; 45: 113-26.
71. Bu X, Rotter Jl. Wolfram syndrome: a mitochondrial mediated disorder. Lancet 1993; 342: 598-600.
72. Bezold R, Hofmann S, Jaksch M, Kaufhold P, Gerbitz KD. DIDMOAD or Wolfram syndrome: a mitochondrial-mediated disorder? Diabetes Care 1995; 18: 583-4.
73. Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bonilla E et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994; 44: 721-7.
74. Bardosi A, Creutzfeldt W, DiMauro S, Felgenhauer K, Friede RL, Goebel H et al. Myo-neuro-gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome c oxidase: A new mitochondrial multisystem disorder. Acta Neuropathol (Berl) 1987; 74: 248-58.
75. Simon L, Horoupian D, Dorfam L, Marks M, Herrick MK, Wasserstein P et al. Polyneuropathy, ophthalmoplegia, leukoencephalopathy and intestinal pseudo-obstruction: POLIP syndrome. Ann Neurol 1990; 28: 349-60.
76. Ionasescu V. Oculogastrointestinal muscular dystrophy. Am J Med Genet 1983; 15: 103-12.
77. Rowland LR Progressive external ophthalplegia and ocular myopathies. In: Vinkens PJ, Bruyn GW, Klawans HL (eds). Handbook of clinical neurology. Vol 62. Amsterdam: Elsevier Science Publishers, 1992: 287-329.
78. Li V, Hostein J, Romero N et al. Chronic intestinal pseudoobstruction with myopathy and ophthalmoplegia: A muscular biochemical study of a mitochondrial disorder. Dig Dis Sci 1991; 37: 456-63.
79. Cormier T, Rötig A, Tardieu M, Colonna M, Saudubray JM, Munnich A. Autosomal dominant deletions of the mitochondrial genome in a case of progressive encephalomyopathy. Am J Human Genet 1991; 48: 643-8.
80. Gómez GM, Mutchinick O, Vega-Boada F, García-Ramos G, Romero V, Barrera-Ramírez CF et al. Encefalopatía mitocondrial neurogastrointestinal (MNCIE). Trabajo presentado en el XXI Congreso Nacional de Genética Humana y 1er. Encuentro Latinoamericano de Bioética y Genoma Humano. Manzanillo, Col, México, 9 al 12 de octubre de 1996.
81. Shoffner JM, Voljavec AS, Dixon J, Kaufman A, Wallace DC, Mitch WE. Renal amino acid transport in adults with oxidative phosphorylalion diseases. Kid Int 1995; 47: 1101-7.
82. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The metabolic and molecular bases of inherited disease. Vol I. USA: McGraw-Hill, 1995: 1535-609.
83. Mohri I, Taniike M, Fujimura, Matsuoka T, Inui K, Nagai T et al. A case of Kearns-Sayre syndrome showing a constant proportion of deleted mitochondrial DNA in blood cells during 6 years of follow-up, J Neurol Sci 1998; 158: 106-9.
84. Ades LC, Gedeon AK, Wilson MJ, Latham M, Partington MW, Mulley JC. Barth syndrome: Clinical features and confirmation of gene localization to distal Xq28. Am J Med Genet 1993; 45: 327-34.
85. Bonilla E, Schotland DL, DiMauro S, Aldover B. Electron cytochemistry of crystalline inclusions in human skeletal muscle mitochondria. J Ultraestruct Res 1975; 51: 404-8.
86. Bonilla E, Schotland DL, DiMauro S. Ultrastructural study of globular inclusions in human skeletal muscle mitochondria. Acta Neurophatol (Berl) 1980; 52: 35-40.
87. Cullen MJ, Fulthorpe JJ. Stages in fiber breakdown in Duchenne muscular dystrophy. An electronmicroscopic study. J Neurol Sci 1975; 24: 179-200.
88. Pearse GW. Electron microscopy in the study of muscular dystrophy. Ann NY Acad Sci 1966; 138: 138-50.
89. Chou SM. "Megaconial" mitochondria observed in a case of chronic polymyositis. Acta Neumphatol (Berl) 1969; 12: 68-89.
90. Chew EC, Araoz C, Sun CN, White HJ. Dermatomyositis: ultrastructure of abnormal mitochondria in the skeletal muscle. Ann Clin Lab Sci 1977; 7: 29-34.
91. Guerrero A, Castro M, Martín-Estefanía C. Aspecto clínico de las enfermedades mitocondriales. Rev Neurol 1988; 26 (suppl 1): S 50-560.
92. Johns DR, Stein AG, Wityk R. MELAS syndrome masquerading as herpes simplex encephalitis. Neurology 1993; 43: 2471-3.
93. Isozumi K, Fukuuchi Y, Tanaka K, Nogawa S, Ishihara T, Sakota R. A MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes) mtDNA mutation that induces subacute dementia which mimicks Creutzfeldt-Jakob disease. Int Med 1994; 33: 543-6.
94. Munnich A, Rustin P, Roting A. Clinical aspects of mitochondrial disorders. J Inherit Metab Dis 1992; 15: 448-55.
95. Ogasahara S, Yorifuji S, Nishikawa Y, Takahashi M, Wada K, Hazama T et al. Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q10 in Kearns-Sayre syndrome. Neurology 1985; 35: 372-7.
96. Ogasahara S, Nishikawa Y, Yorifuji S, Soga F, Nakamura Y, Takahashi M et al. Treatment of Kearns-Sayre syndrome with coenzyme Q10. Neurology 1986; 36: 45-53.
97. Bresolin N, Bet L, Binda A, Moggio M, Comi G, Nador F et al. Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10. Neurology 1988; 38: 892-9.
98. Bresolin N, Doriguzzi C, Ponzetto C, Angelini C, Moroni I, Castelli E et al. Ubidecarenone in the treatment of mitochondrial myopathies: a multicenter double-blind trial. J Neurol Sci 1990; 100: 70-8.
99. Matthews PM, Ford B, Dandurand RJ, Eidelman DH, O'Connor D, Sherwin A et al. Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease. Neurology 1993; 43: 884-90.
100. Nakagawa E, Osari S, Yamanouchi H, Matsuda H, Goto Y, Nonaka I. Long-term therapy with cytochrome c, flavine mononucleotide and thiamine diphosphate for a patient with Kearns-Sayre syndrome. Brain Dev 1996; 18: 68-70.
101. Bernsen PL, Cabreëls FJ, Ruitenbeek W, Sengers RC, Stadhouders AM, Renier WO. Succesful treatment of pure myopathy, associated with complex I deficiency, with riboflavin and carnitine. Arch Neurol 1991; 48: 334-8.
102. Roodhooft AM, Van Acker KJ, Martin JJ, Ceuterick C, Scholte HR, Luyt-Houwen IE. Benign mitochondrial myopathy with deficiency of NADH-CoQ reductase and cytochrome c oxidase. Neuropediatrics 1986; 17: 221-6.
103. De Stefano N, Matthews PM, Ford B, Genge A, Karpati G, Arnold DL. Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 1995; 45: 1193-8.
104. Mashima Y, Hiida Y, Oguchi Y. Remission of Leber's hereditary optic neuropathy with idebenone. Lancet 1992; 340: 368-9.
105. Kitoh T, Mizuno K, Otagiri T, Ichinose A, Sasao J, Goto H. Anesthetic management for a patient with Kearns-Sayre syndrome. Anesth Analg 1995; 80: 1240-2.
106. Luft R. The development of mitochondrial medicine. Proc Natl Acad Sci USA 1994; 91: 8731-8.
107. Johns DR. Mitochondrial DNA and diseases. N Engl J Med 1996; 334: 270-1.
108. Wallace DC. Mitochondrial genetics: A paradigm for aging an degenerative diseases? Science 1992; 256: 628-32.
109. Enríquez JA, Martínez-Azorín F, Garesse R, López-Pérez MJ, Pérez-Martos A, Borstein B, Montoya J. Sistema genético mitocondrial humano. Rev Neurol 1998; 26 (supl 1): S21-S26.
110. Stoneking M, Soodyall H. Human evolution and the mitochondrial genome. Curr Opin Genet Dev 1996; 6: 731-6.